Nasdaq News

Fintel reports that on September 29, 2026, Scotiabank initiated coverage of Xcel Energy Inc. - Preferred Stock (NASDAQGM:XELLL) with a Sector Outperform recommendation. On the day of the coverage initiation, September 29, 2026, the stock's latest close was $20.96. This followed a

Key PointsBroadcom's fourth-quarter gains since 2013 ran from under 3% to around 37%.

Key PointsMuse could be a major catalyst for Shopify, giving new merchants another reason to choose the platform.

(RTTNews) - Takeda Pharmaceutical Company Ltd. (TAK, 4502.T) announced new data from three Phase 3 LATITUDE psoriasis studies of zasocitinib (TAK-279) in adults with moderate-to-severe plaque psoriasis.

(RTTNews) - Roche Holding AG (RHHBY), a healthcare company, announced two regulatory developments, with the U.S. FDA accepting its New Drug Application (NDA) for Fenebrutinib in relapsing multiple sclerosis and primary progressive multiple sclerosis under Priority Review.

(RTTNews) - AbbVie (ABBV) announced positive interim results from the Phase 2 APEX Part B dose-regimen-finding Study of zumilokibart in adult patients with moderate to severe atopic dermatitis, supporting further development of the investigational therapy.

Key PointsOracle's rising bond yields have raised concerns about how the AI build-out will be financed moving forward.

(RTTNews) - A strong positive sentiment is expected to prevail in European stock markets on Wednesday amidst a sharp decline in Fed rate hike expectations. The decline in crude oil prices, the easing in bond yields and the dollar's retreat are also expected to bolster sentiment.

(RTTNews) - Swiss drug major Roche Holding AG (RHHBY, RO.SW, ROG.SW) announced Wednesday the launch of newborn screening test for three severe genetic conditions, such as Spinal Muscular Atrophy or SMA, Severe Combined Immunodeficiency Disease or SCID, and Sickle Cell Disease or

(RTTNews) - TomTom N.V. (TOM2.AS), a location technology specialist, Wednesday announced its expanded collaboration with major global technology company, Microsoft (MSFT), bringing TomTom's location intelligence to AI agents built on Microsoft Fabric and Microsoft Foundry through

META's Muse is reshaping the agentic AI race with massive distribution, user data and a free offering.

(RTTNews) - AbbVie (ABBV) reported positive results from the Phase 2 APEX Part B study of zumilokibart, in adults with moderate to severe atopic dermatitis.

(RTTNews) - Takeda Pharmaceutical Company Ltd. (TAK,4502.T) announced new data from three Phase 3 LATITUDE psoriasis studies of zasocitinib (TAK-279) in adults with moderate-to-severe plaque psoriasis.

(RTTNews) - Galderma (GALD) announced new three-year results from the ARCADIA long-term extension study showing that Nemluvio (nemolizumab) was associated with sustained improvements in patients with moderate-to-severe atopic dermatitis.

MU's earnings report will spotlight booming DRAM and NAND demand, memory pricing and whether AI-driven growth can stay strong.

(RTTNews) - Galderma (GALD) reported new three-year data from the ARCADIA long-term extension study showing that Nemluvio (nemolizumab) was associated with sustained improvements in skin lesions, itch, sleep disturbance and quality of life in adults and adolescents with moderate-

(RTTNews) - Dyne Therapeutics (DYNE) announced on Tuesday additional one-year clinical data from the Phase 1/2 ACHIEVE trial of investigational Z-basivarsen showing sustained functional improvements across multiple measures in patients with myotonic dystrophy type 1.

(RTTNews) - Genentech, affiliated to Swiss drug major Roche Holding AG (RHHBY, RO.SW, ROG.SW) announced Wednesday that the U.S. Food and Drug Administration has accepted its New Drug Application or NDA under priority review for fenebrutinib in both relapsing and primary progressi

Key PointsOracle spent $28.5 billion on capital expenditures last quarter, far more than its $19.3 billion in revenue.

(RTTNews) - The Walt Disney Company (DIS) is eliminating hundreds of jobs in its human resources and technology functions, Reuters reported, citing a source familiar with the matter.